One of the main challenges in LANA research is the complexity of its interactions with host cell proteins and the multifaceted roles it plays in viral latency and oncogenesis. Additionally, the immune evasion strategies employed by KSHV add another layer of difficulty. Developing specific inhibitors that can effectively target LANA without adversely affecting normal cellular functions remains a significant hurdle.
